2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.

Slides:



Advertisements
Similar presentations
Chapter 7: Pediatric ESRD 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Advertisements

Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Vol 2, ESRD, Ch ANNUAL DATA REPORT VOLUME 2: END-STAGE RENAL DISEASE Chapter 9: Costs of ESRD.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 4: Cardiovascular Disease in Patients With CKD 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.
Chapter 6: Medicare Expenditures for CKD 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Vol 2 Figure 1.1 Trends in the number of incident cases of ESRD, in thousands, by modality, in the U.S. population, Data Source: Reference.
Stages of CKD – KDOQI 2002 Definitions
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 5: Acute Kidney Injury 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter i: Introduction 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 3: Morbidity & Mortality 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
Chapter 4: Cardiovascular Disease in Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 9: Cardiovascular Disease in Patients With ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 11: Costs of ESRD.
Introduction 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
(lines; scale on left) in the U.S. population,
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 14: End-of-life Care for Patients with End-Stage Renal Disease:
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
Chapter 6: Medicare Expenditures for Persons with CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 7: Medicare Part D Prescription Drug Coverage in Patients with Chronic Kidney Disease 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 12: Part D Prescription Drug Coverage in Patients with ESRD.
Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 4: Vascular Access.
at risk) for Medicare patients aged 66 and older, by CKD status, 2013
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
2016 Annual Data Report, Vol 1, CKD, Ch 4
Figure 9.1 Causes of death in ESRD patients,
Figure 11.1 Trends in ESRD expenditures,
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
Table 6.1 Prevalent Medicare fee-for-service patient counts and spending for beneficiaries aged 65 and older, by DM, CHF, and/or CKD, 2014 U.S. Medicare.
Chapter 2: Identification and Care of Patients With CKD
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
2016 Annual Data Report, Vol 1, CKD, Ch 2
Chapter 8: Cardiovascular Disease in Patients with ESRD
2017 Annual Data Report Healthy People 2020.
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Volume 1: Chronic Kidney Disease
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
December 31st point prevalent counts by modality figure 3.1
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
Volume 1: Chronic Kidney Disease Chapter 3: Morbidity and Mortality
Chapter 9: Healthcare Expenditures for Persons with ESRD
2016 Annual Data Report, Vol 2, ESRD, Ch 14
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 6: CKD among Children and Adolescents
2016 Annual Data Report, Vol 1, CKD, Ch 3
2018 Annual Data Report Volume 3: Healthy People 2020
Chapter 4: Cardiovascular Disease in Patients with CKD
2018 Annual Data Report Volume 1: Chronic Kidney Disease
Chapter 3: Morbidity and Mortality
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
Chapter 2: Identification and Care of Patients with CKD
Chapter 8: Cardiovascular Disease in Patients with ESRD
Figure 9.1.a Causes of death in ESRD patients,
Chapter 2: Identification and Care of Patients with CKD
Presentation transcript:

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization

Data Source: Reference tables: G.1, G.3, G.4, G.5, G.6, G.8, G.9, G.10, and special analyses, USRDS ESRD Database. Period prevalent ESRD patients; adjusted for age, sex, race, & primary diagnosis; ref: ESRD patients, Abbreviations: ESRD, end-stage renal disease. Figure 5.1 Adjusted hospitalization rates for ESRD patients, by treatment modality, Vol 2, ESRD, Ch 52

3Vol 2, ESRD, Ch 1 Data Source: Reference tables: G.1, G.3, G.4, G.5, and special analyses, USRDS ESRD Database. Period prevalent ESRD patients; adjusted for age, sex, race, & primary diagnosis; ref: ESRD patients, Abbreviations: ESRD, end-stage renal disease. Figure 5.2 Adjusted all-cause & cause-specific hospitalization rates for ESRD patients, by treatment modality, (a) All ESRD

4Vol 2, ESRD, Ch 1 Data Source: Reference tables: G.1, G.3, G.4, G.5, and special analyses, USRDS ESRD Database. Period prevalent ESRD patients; adjusted for age, sex, race, & primary diagnosis; ref: ESRD patients, Abbreviations: ESRD, end-stage renal disease. Figure 5.2 Adjusted all-cause & cause-specific hospitalization rates for ESRD patients, by treatment modality, (b) Hemodialysis

5Vol 2, ESRD, Ch 1 Data Source: Reference tables: G.1, G.3, G.4, G.5, and special analyses, USRDS ESRD Database. Period prevalent ESRD patients; adjusted for age, sex, race, & primary diagnosis; ref: ESRD patients, Abbreviations: ESRD, end-stage renal disease. Figure 5.2 Adjusted all-cause & cause-specific hospitalization rates for ESRD patients, by treatment modality, (c) Peritoneal Dialysis

6Vol 2, ESRD, Ch 1 Data Source: Reference tables: G.1, G.3, G.4, G.5, and special analyses, USRDS ESRD Database. Period prevalent ESRD patients; adjusted for age, sex, race, & primary diagnosis; ref: ESRD patients, Abbreviations: ESRD, end-stage renal disease. Figure 5.2 Adjusted all-cause & cause-specific hospitalization rates for ESRD patients, by treatment modality, (d) Transplant

7Vol 2, ESRD, Ch 1 Data Source: Reference Tables G.3, G.13, and special analyses, USRDS ESRD Database. Period prevalent hemodialysis patients aged 22 & older; adjusted for age, sex, race, ethnicity, & primary cause of kidney failure. Rates by one factor adjusted for the remaining three; reference group, hemodialysis patients, See Vol. 2, ESRD Analytical Methods for principal ICD-9-CM diagnosis codes included in each cause of hospitalization category. Table 5.1 Rates of all-cause & cause-specific hospitalization per patient year for adult hemodialysis patients, AllCardiovascularInfection (any) Vascular access infection UnadjustedAdjustedUnadjustedAdjustedUnadjustedAdjustedUnadjustedAdjusted Age Sex Male Female Race White Black/African American Other race Ethnicity Hispanic Cause of Renal Failure Diabetes Hypertension Glomerulonephritis Other

8Vol 2, ESRD, Ch 1 Data Source: Reference Tables G.1, G.3, G.4, G.5, G.6, G.8, G.9, G.10, and special analyses, USRDS ESRD Database. Period prevalent ESRD patients; adjusted for age, sex, race, & primary cause of kidney failure. Reference group: ESRD patients, Abbreviation: ESRD, end-stage renal disease. Figure 5.3 Adjusted hospital days for ESRD patients, by treatment modality,

9Vol 2, ESRD, Ch 1 Data Source: Special analyses, USRDS ESRD Database. Period prevalent ESRD patients, adjusted for age, sex, race, & primary cause of kidney failure; reference group: ESRD patients, Abbreviation: ESRD, end-stage renal disease. Figure 5.4 Adjusted hospital days for infection & cardiovascular causes, for ESRD patients by their treatment modality, (a) Infection

10Vol 2, ESRD, Ch 1 Data Source: Special analyses, USRDS ESRD Database. Period prevalent ESRD patients, adjusted for age, sex, race, & primary cause of kidney failure; reference group: ESRD patients, Abbreviation: ESRD, end-stage renal disease. Figure 5.4 Adjusted hospital days for infection & cardiovascular causes, for ESRD patients by their treatment modality, (b) Cardiovascular

11Vol 2, ESRD, Ch 1 Data Source: Special analyses, USRDS ESRD Database and Medicare 5 percent sample. January 1, 2013 point prevalent Medicare patients aged 66 & older on December 31, For general Medicare: January 1, 2013 point prevalent, Medicare patients aged 66 & older, discharged alive from an all-cause index hospitalization between January 1, 2013, and December 1, 2013, unadjusted. CKD determined using claims for Abbreviations: CKD, chronic kidney disease; ESRD, end-stage renal disease; rehosp, rehospitalization. Figure 5.5 Proportion of patients aged 66 & older discharged alive from the hospital who either were rehospitalized or died within 30 days of discharge, by kidney disease status, 2013

12Vol 2, ESRD, Ch 1 Data Source: Special analyses, USRDS ESRD Database. Period prevalent hemodialysis patients, all ages, 2013; unadjusted. Includes live hospital discharges from January 1 to December 1, Cause-specific hospitalizations are defined by principal ICD-9-CM codes. See Vol. 2, ESRD Analytical Methods for principal ICD-9-CM diagnosis codes included in each cause of hospitalization category. Abbreviations: Af Am, African American; ESRD, end-stage renal disease; Nat Am, Native American; Other, other or unidentified race; rehosp, rehospitalization. Figure 5.6 Proportion of hemodialysis patients discharged alive from the hospital who either were rehospitalized or died within 30 days of discharge, by demographic characteristics, 2013 (a) By age

13Vol 2, ESRD, Ch 1 Data Source: Special analyses, USRDS ESRD Database. Period prevalent hemodialysis patients, all ages, 2013; unadjusted. Includes live hospital discharges from January 1 to December 1, Cause-specific hospitalizations are defined by principal ICD-9-CM codes. See Vol. 2, ESRD Analytical Methods for principal ICD-9-CM diagnosis codes included in each cause of hospitalization category. Abbreviations: Af Am, African American; ESRD, end-stage renal disease; Nat Am, Native American; Other, other or unidentified race; rehosp, rehospitalization. Figure 5.6 Proportion of hemodialysis patients discharged alive from the hospital who either were rehospitalized or died within 30 days of discharge, by demographic characteristics, 2013 (b) By race/ethnicity

14Vol 2, ESRD, Ch 1 Data Source: Special analyses, USRDS ESRD Database. Period prevalent hemodialysis patients, all ages, 2013, unadjusted. Includes live hospital discharges from January 1 to December 1, Cause-specific hospitalizations are defined by principal ICD-9-CM codes. See Vol. 2, ESRD Analytical Methods for principal ICD-9-CM diagnosis codes included in each cause of hospitalization category. Abbreviations: CVD, cardiovascular disease; ESRD, end-stage renal disease; rehosp, rehospitalization; VA, vascular access. Figure 5.7 Proportion of hemodialysis patients discharged alive that either were rehospitalized or died within 30 days of discharge, by cause of index hospitalization, 2013

15Vol 2, ESRD, Ch 1 Data Source: Special analyses, USRDS ESRD Database. Period prevalent hemodialysis patients, all ages, 2013, unadjusted. Includes live hospital discharges from January 1 to December 1, Cause-specific hospitalizations are defined by principal ICD-9-CM codes. See Vol. 2, ESRD Analytical Methods for principal ICD-9-CM diagnosis codes included in each cause of hospitalization category. Abbreviations: CVD, cardiovascular disease; ESRD, end-stage renal disease; rehosp, rehospitalization; VA, vascular access. Figure 5.8 Proportion of hemodialysis patients with cause-specific rehospitalizations within 30 days of discharge, by cause of index hospitalization, 2013

16Vol 2, ESRD, Ch 1 Data Source: Special analyses, USRDS ESRD Database. Period prevalent hemodialysis patients, all ages, 2013, unadjusted. Patients less than age 22 are not represented as a group due to insufficient sample size. Includes live hospital discharges from January 1 to December 1, Cause-specific hospitalizations are defined by principal ICD-9-CM codes. See Vol. 2, ESRD Analytical Methods for principal ICD-9-CM diagnosis codes included in each cause of hospitalization category. Abbreviations: CVD, cardiovascular disease; ESRD, end-stage renal disease; rehosp, rehospitalization. Figure 5.9 Proportion of hemodialysis patients discharged alive that either were rehospitalized or died within 30 days of discharge for cardiovascular index hospitalization, by age, 2013

17Vol 2, ESRD, Ch 1 Data Source: Special analyses, USRDS ESRD Database. Period prevalent hemodialysis patients, all ages, 2013, unadjusted. Includes live hospital discharges from January 1 to December 1, Cause-specific hospitalizations are defined by principal ICD-9-CM codes. See Vol. 2, ESRD Analytical Methods for principal ICD-9-CM diagnosis codes included in each cause of hospitalization category. Abbreviations: AMI, acute myocardial infarction; CHF, congestive heart failure; ESRD, end-stage renal disease; rehosp, rehospitalization. Figure 5.10 Proportion of hemodialysis patients discharged alive that either were rehospitalized or died within 30 days of discharge for cardiovascular index hospitalization, by cause-specific cardiovascular index hospitalization, 2013